The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study

Volume: 12, Issue: 1
Published: Aug 16, 2021
Abstract
Intraperitoneal administration of BromAc (bromelain + acetylcysteine) is currently undergoing a phase 1 clinical trial for pseudomyxoma peritonei at our institution. This study reports on analysis of routine blood parameters before and after treatment for a series of 25 patients in this trial. Blood parameters assessed included full blood count, electrolytes, urea, and creatinine, liver function tests, coagulation studies, as well as...
Paper Details
Title
The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study
Published Date
Aug 16, 2021
Volume
12
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.